Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 30 Medical Device Angel Investors in Israel in November 2024

Last updated: Nov 2024 A list of 30 angel investors that invest in Medical device startups based in Israel. We rank investors based on the number of investments they made in Medical device companies from Israel. We update this investor list every month.

Top 30 Medical Device Angel Investors in Israel in November 2024

Investor	Medical Device Israel investments
Shimon Eckhouse	2
Zohar Gilon	2
Prof. Rafael Beyar	2
Ron C	2
Mazal CB	2
Yehuda Zisapel	2
Alan Patricof	1
Marius Nacht	1
Oren Dobronsky	1
Lewis Pell	1
Zohar Zisapel	1
Jeremy Coller	1
Jacques R. Seguin	1
Rafi Gidron	1
Moshe Gaon	1
Shahar Tzafrir	1
Moshe Yanai	1
Dov Moran	1
Michal Efrat Zarfati	1
Itsik Danziger	1
Daniel Koss	1
Ole T. Jensen	1
Avi Kornreich	1
Tzachi Arabov	1
Jim Elkind	1
Amir Gross	1
Ran Tuttnauer	1
Benny Levin	1
Rafi Benary	1
Danny Hadar	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Shimon Eckhouse, Ph.D., is a leading Israeli medical entrepreneur who has founded more than 20 startups including Syneron Medical Ltd., Lumenis Ltd., Ventor and Real-View Imaging. He is the current Chairman of Butterfly Medical Ltd, Active Chairman of Synerion Medical and serves as Executive of Matteris Ltd. Shimon Eckhouse served as the ChiefExecutive Officer of Syneron Medical Ltd. from April 17, 2013 to February 18, 2014. Shimon Eckhouse Co-Founded Colorchip Inc. in 2000 and served as its Chairman from 2003 to January 2004 and as Chief Executive Officer from 2001 to 2003. He served as the Chairman and Chief Executive Officer of ESC Medical Systems since its inception in 1992. He was also a co-founder and Chairman of Ventor Medical Technologies Ltd. He Co-Founded at Navotek Medical Ltd. Mr. Eckhouse took ESC public in 1996 and raised more than $250M in public offerings. He served as Chairman of Syneron Medical Ltd. from May 2004 to May 2013. He worked at Lumenis Ltd. Prior to that, Shimon Eckhouse served as Head of Product Development and Technical Director at Maxwell Technologies in San Diego, California. From 1969 to 1986, he worked at Rafael, Armament Development Authority of Israel as a Scientist, Team Leader and Head of Department and was active in various areas of research and development including lasers and electro-optics. Shimon Eckhouse has been the Founder of Orsense, Ventor, Tulip, Cardiodex, Opticul Diagnostic, C3D and NanoCyte, Inc. Shimon Eckhouse serves as the Chairman of Fluorinex Active Ltd. Shimon Eckhouse serves as the Chairman at Starling Advanced Communications Ltd. since July 2010. He serves as Chairman at OrSense Ltd. He also serves as the Chairman of the Board of Ossense Ltd., Navotek Medical Ltd., and Replicom Ltd. and Edge Medical Devices Ltd. He has been a Director at Syneron Medical Ltd. since May 2004. He serves as a Director of Cardiodex and NanoCyte, Inc. Shimon Eckhouse serves as a Member of Advisory Board of Agate Medical Investments LP and JGV Growth Equity Fund, L.P. Shimon Eckhouse serves as a Director of the Technion Israeli Institute of Technology. He served as a Director of Zend Technologies Ltd. He served as a Director of WideMed Ltd. Shimon Eckhouse has more than 25 registered patents and published more than 50 papers in leading reference journals and conferences. He holds a Ph.D. in Physics from the University of California at Irvine and a B.Sc. in Physics from the Technion Israeli Institute of Technology.

Investment focus

Health Care, Medical Device, Medical
Series B, Series C, Funding Round
Israel

Portfolio highlights

Anchora Medical — Anchora Medical focuses in simplifying of suturing in endoscopic and open surgery applications. The company develops a unique, single-use automatic suturing device for minimal invasive surgery.
Serenno Medical — Serenno Medical is a medical device company creating a urine-output measuring device for the ICU. The company is the developer of a bedside urine output measuring device for hospitalized patients, offering accurate and automatic measurements with low costs, less workload, and improved patient safety.Serenno Medical was founded in 2017 and isheadquartered in Yokne'am Illit, Israel.
RealView Imaging — RealView Imaging is pioneering the field of interactive live holography, creating a new dimension for Augmented Reality applications.

Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.

Investment focus

Software, Internet, Health Care
Seed, Series A, Series B
Israel, United States

Portfolio highlights

CADY — CADY utilizes AI technology to automate the analysis of electrical schematics
Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.

Prof. Rafael Beyar

Investment focus

Medical, Medical Device, Machine Learning
Seed, Series A
Israel

Portfolio highlights

MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).

Ron C

Investment focus

Health Care, Therapeutics, Medical Device
Seed, Pre-Seed
Israel

Portfolio highlights

DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.

Mazal CB

Investment focus

Health Care, Therapeutics, Medical Device
Seed, Pre-Seed
Israel

Portfolio highlights

DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.

Mr. Yehuda Zisapel (EE,MSc, MBA, DHC) is the founder and president of the RAD-Bynet Group, a leading pioneering association of Israeli companies active in the development, production and marketing of innovative solutions for the data communications industry, and Chairman of RAD. The RAD-Bynet Group grew out of Bynet Data Communications, whichMr. Zisapel founded in 1975 as a small private company that marketed data communications products. Bynet represented major international vendors and was the first to introduce cutting-edge technologies into the Israeli market. Today, the Bynet Group is comprised of eight companies active in both the Israeli and Eastern European markets in such fields as systems integration, cabling, testing, outsourcing, and software development. Following the arrival of Mr. Zisapel’s brother, Zohar, who joined him in 1981, a wide range of industrial activity was spawned from within the newly established RAD, the first of the RAD Group companies. In the years following its successful launch, twenty-four additional independent hi-tech companies were opened to develop, produce and market a wide variety of advanced data communications products.

Investment focus

Medical Device, Medical, Health Care
Funding Round, Series A, Seed
Israel

Portfolio highlights

Carteav — Our mission is to create and distribute autonomous low-speed vehicles (LSVs) that inspire mass-market adoption on a global scale.
Rewire — Secure financial services designed to help migrants make cross-border money transfers. Rewire offers great rates, fast delivery, multilingual customer support
Laminate Medical — Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the firstyear. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications.

Alan Patricof is the founder and Chairman Emeritus and was a managing director of Greycroft. He is a Co-founder and Chairperson at Primetime Partners and was a Founder at Apax Partners. Alan attended Columbia Business School and The Ohio State University.

Investment focus

Financial Services, Finance, Health Care
Series A, Seed, Funding Round
United States, Kenya, Spain

Portfolio highlights

Leena AI — Leena AI is a Gen AI employee assistant that reduces IT, HR, Finance tickets. We guarantee 70% self-service ratio in the contract.
Racket — Let's make a racket.
Alpha Tau Medical — Alpha Tau Medical provides highly potent and conformal Alpha Radiotherapy (Alpha DaRT) for solid cancer tumors.

Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.

Investment focus

Artificial Intelligence, Machine Learning, Health Care
Series A, Funding Round, Seed
Israel, United States, Germany

Portfolio highlights

CPTx — At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
Wisdo Health — Our award-winning social health platform utilizes SDOH assessments and pro-social measures to increase quality of life and decrease medical spending.
WaveBL — WAVE BL lets you digitally issue, transfer, sign, endorse and surrender trade documents while cutting costs and eliminating fraud.

Entrepreneur at heart. Angel investor in past two decades. I had the privilege to invest in the following startups, mostly at seed level: Houzz(Unicorn), TripActions(Unicorn), Hippo(Unicorn), HomeLight, Domestika, Loop Commerce, RedKix, Duda, YouNow, OwnerListens... But mostly, I am known as Oren from Oren's Hummus :)

Investment focus

FinTech, Software, Customer Service
Seed, Series A, Angel
United States, Israel

Portfolio highlights

Openbase — Find and compare the best open-source packages in hundreds of categories - withpowerful metrics and user reviews
Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
Annabella Tech — Annabella is the only breast pump in the world with a patented mechanism that replicates the tongue and other inner parts of the baby's mouth. By simulating baby's suckling motion, the pump triggers mothers' natural reflex, allowing more milk to be extracted in less time. Annabella is small, quiet, portable and rechargeable - it canbe used in any place at any time and fit to a small hand bag. It has only two parts that needs to be washed and assembled. It is controlled by an app that records the pumping session and adjusts the pumping plan to fit to the mothers' personal need or suggests a better suited one.

Lewis Pell was appointed to our Board of Directors and was unanimously elected to serve as Non-Executive Chairman of the Board on December 12, 2011. Pell was a member of Radiancy’s Board since 1998. Pell has founded over a dozen successful medical technology companies during the past three decades. In 1979, he founded Pentax PrecisionInstruments, which was sold to Asahi Optical Co. in 1990. In 1983, he founded American Endoscopy Inc., which was sold to C.R. Bard, Inc. (BCR-NYSE) in 1986. In 1984, he founded Versaflex Inc., which was sold to Medtronic in 1988. In 1989, he founded Heart Technology Corp., which went public in the U.S. in 1992 and was sold to Boston Scientific Corp. (BSX-NYSE) in 1995. In 1991, he founded InStent Inc., which became a public company in 1995 and was sold to Medtronic in 1996. In 1994, he founded Influence Inc., which was sold to American Medical Systems Inc. in 1999. Working with Shlomo Ben-Haim, Pell founded Biosense Inc. in 1994, which was sold to Johnson & Johnson in 1997. He is currently chairman and an investor for a number of private medical device companies. In 1992, he founded and remains the chairman of Vision-Sciences, Inc. (VSCI-NASDAQ). Pell has a B.S. in political science from Brooklyn College and over 20 years of experience in the medical technology industry. Pell was selected to serve on the Company’s board because of his over thirty-years’ experience in leadership roles in the medical device industry.

Investment focus

Health Care, Medical, Therapeutics
Funding Round, Post-IPO Equity
Israel, United States

Portfolio highlights

Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
Vision Sciences — Vision-Sciences, Inc., is a medical device company. The Company designs, develops, manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, EndoSheath technology. The Company produces and markets Endoscopes, such as cystoscopes, ureteroscopes, laryngoscopes,otoscopes, sinuscopes, trans-nasal esophagoscopy (TNE) and bronchoscopes for medical use and borescopes for industrial use, and digital processing units (DPU). The Company offers Urgent PC Neuromodulation System, a nerve stimulation device that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). It also offers Macroplastique, an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence. It markets additional bulking agents: PTQ for the treatment of fecal incontinence and the VOX for vocal cord augmentation.

Zohar Zisapel

Investment focus

Cyber Security, Information Technology, Security
Series A, Seed, Series B
Israel, United States

Portfolio highlights

Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
Nucleix — OUR TESTS AIM TO DETECT CANCER EARLIER - WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS
Hailo — Hailo have developed the best performing AI processors for edge devices. Our AI accelerator chips are used for Smart City & Homes, machine learning, automotive AI, retail AI and smart factory Industry 4.0 solutions.

Jeremy Coller founded the business in 1990.Prior to this, Jeremy spent five years at Imperial Chemical Industries (ICI) Investment Management, where he pioneered the acquisition of private equity secondaries.He began his career as a public equities investment analyst at Fidelity International Investment Management in London.Jeremy holds aBSc (Hons) in Management Sciences from the University of Manchester, UMIST; an MA in Philosophy from Sussex University; and a Diplôme Cours de Civilisation from the Sorbonne. He attended Carmel College.

Investment focus

News, Video, Mobile
Seed, Pre-Seed, Series A
Israel, United Kingdom

Portfolio highlights

Castor Technologies — CASTOR is a complete decision support system for utilizing industrial additive manufacturing
Penfold — Our flexible, simple and powerful pension is designed to get you to your saving goals and stay with you for life, whichever direction it takes you.
X-trodes — X-trodes is a technology start-up that develops unique wearable, wireless technology, and advanced analytics of biopotential signals.

Jacques Seguin is the Chairman Of The Board at Emanate Biomedical.

Investment focus

Medical, Medical Device, Health Care
Seed, Pre-Seed, Funding Round
Israel, Switzerland

Portfolio highlights

Pi-Cardia — Pi-Cardia. Next Generation Valve Repair. The next frontier of treatment options for structural heart disease that provides a safe, effective, and affordable non-implant-based catheter solutions.
Althea Medical — Althea Medical is a creator of catheter devices for the treatment of patients with sub- or major pulmonary emboli. The company is developing a catheter-based solution for treating patients suffering from massive and sub-massive Pulmonary Embolism (PE). Althea Medical was established in 2020 in Tel Aviv, Israel.
CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

Rafi Gidron is the Chairman and Co-Founder of Xperiti. He attended Columbia University.

Investment focus

Artificial Intelligence, Cyber Security, Financial Services
Seed, Angel, Series B
Israel, United States, United Kingdom

Portfolio highlights

Vyzer — One platform for investment tracking, financial planning, data-driven insights, document analysis & more! Ideal for diverse portfolios.
GlossAI — Detect, analyze, and monitor every brand-related video with GlossAi's Social Watching platform. Enhance your brand protection, get video insights, real-time marketing, and influencer selection. Monitor and analyze videos to elevate your brand's online presence today!
The Digital Dogs Company — A cross-app personal AI Digital Dogs platform for VR worlds,Social apps,Games and more. Digital Dogs are driven by powerful artificial intelligence technologies and nurtured by your voice, gestures, emotions, and a digital environment. You can train your Digital Dog to do tricks and perform in competitions, care for them and breed them. AllDigital Dogs are secured as NFTs on the Ethereum blockchain and can be sold, swapped, and shared with other users.

Business entrepreneur and investor in startups. For the past 20 years developer of new initiatives and ideas. CEO, Chairman of companies, political strategist and advertising expert. Lead public opinion campaigns for people and issues from breast cancer, to national elections to the Israeli-Palestinian peace negotiations. Founding Partner atmybulb.vcOwner of the Gaon Holding Group; Executive Director in the group's companies, focusing on development and marketing products and services for the global Water Smart Grid. Member of the AquaAgro Fund Investment committee, a 50 Million dollar Israeli Venture Capital Fund, focused only on developing innovative water and agriculture technologies, as well as other innovative clean technologies.

Investment focus

Advertising, Association, Social Media Marketing
Seed, Series A, Convertible Note
Israel, United States

Portfolio highlights

Apester — Supercharge your marketing and funnel with interactive content experiences that generate more leads, engage and convert users, and boost retention
Yoocan — Yoocan is a global community for people with disabilities and their families, discover empowering stories, find support, and connect with a world that understands you.
IndieFlow — IndieFlow developed a workflow management platform for the music industry. The platform provides a centralized platform to manage music industry workflows and streamline the major building blocks of an artist’s career. It enables users to manage creative projects, distribute to streaming platforms, collect roylaties, register music with royaltycollection societies, promote music, book gigs, receive payments and more.

Shahar is a Managing Partner at TLV Partners, investing in the idea/seed stage. Over the past decade, he has focused on the intersection of AI as it addresses commercial problems across sectors, including Developer Tools, Biotech, Cloud Native, Construction, Customer Retention, Data Centers, Drug Discovery, Enterprise Software, Health Care,and Taxes.His investment portfolio at TLV Partners includes Buildots, Bond (acquired by Reef), Canopy Immuno-Therapeutics, Covver, Churney, Deepcure, EverAfterAI, Gelt, Granulate (acquired by Intel), Guesty (exit via secondary), Immunai, Odo (acquired by Checkpoint), ScyllaDB, Solvo, Silverfort, and Unleash. He also serves as a Board Observer at Aidoc on behalf of the founders.Before joining TLV Partners, Shahar was a General Partner at Magma Venture Partners, working with funds III and IV. His investment portfolio included Aidoc, Applitools (acquired by Thoma Bravo), Cloudendure (acquired by Amazon), Coretigo, Guesty (exit via secondary), Indegy (acquired by Tenable), ScyllaDB, Syte, Teridion, and Tonkean.Before his venture capital career, Shahar spent 15 years across three startups: Federation (acquired by Cordys), Oblicore (acquired by CA), and DigitalFuel (acquired by VMWare).He served as a software programmer in Israel’s Defense Forces for six years, earning three annual distinction awards at the Unit, Division, and Corps levels.He holds an LL.B., graduating Summa Cum Laude as the Valedictorian. Outside work, he is an amateur nature photographer and a chess player interested in Advanced Chess, a blend of AI and human strategy.

Investment focus

Software, Artificial Intelligence, Information Technology
Series A, Seed, Series B
Israel, United States

Portfolio highlights

Aidoc — Aidoc is an Israel-based startup providing artificial intelligence tools for radiologists. Their products help detect and pinpoint critical anomalies for radiologists through deep learning and AI algorithms that analyze medical images and patient data. Aidoc eases up the work list and frees up time and attention to what matters. The startupdeidentifies these and sends them onto Aidoc’s cloud, where algorithms identify and highlight abnormalities before returning the images to radiology workstations for reidentification.Aidoc's s solutions aid radiologists in reducing turnaround time and increasing quality and efficiency by flagging acute anomalies in real-time. It also offers tests for intracranial hemorrhages and spinal fractures, plus several chest exams for pulmonary embolisms, pneumothorax, rib fractures, and lung nodules.Aidoc was founded by Guy Reiner, Elad Walach, and Michael Braginsky in 2016 and is headquartered in Tel Aviv, Israel.
Buildots — AI-powered progress tracking that accurately measures site performance and reduces delays by up to 50%.
DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t

Moshe Yanai has been instrumental in the development of some of the most advanced and successful storage technologies in the history of the industry. Mr. Yanai began his career in the 1970s, building IBM-compatible mainframe storage based on minicomputer disks. He went on to develop high-end storage systems for Nixdorf, and in the late 1980s,joined EMC, leading the team that developed Symmetrix (today’s “DMX series”). As Vice President of EMC’s Symmetrix group, Mr. Yanai was responsible for design and development of all hardware and software products for EMC’s industry-leading enterprise storage systems. Based in Hopkinton, Massachusetts, EMC’s Symmetrix group grew from only one employee in 1987 to more than 3500 under his leadership. Mr. Yanai graduated in 1975 from the Technion, Israel Institute of Technology with a Bsc in Electrical Engineering. He holds over 40 patents for various innovative storage hardware and software-related technologies.

Investment focus

Artificial Intelligence, Data Storage, Medical
Seed, Series B, Series D
Israel, United States

Portfolio highlights

Infinidat — Infinidat's enterprise storage solutions offer the performance, flexibility and reliability necessary to support today's data intensive enterprises.
Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.

Dov Moran is the Managing Partner of Grove Ventures. He previously worked at modu as the Founder, Chairman, and CEO. Dov Moran attended Technion.

Investment focus

Semiconductor, Hardware, Health Care
Series A, Seed, Series B
Israel, United States

Portfolio highlights

Rapid — RapidAPI is an API Hub that enables over 3 million developers to find, manage, and connect to APIs. RapidAPI lets developers manage all API integrations from one place and gives real-time performance metrics. RapidAPI was founded in 2014 and is headquartered in San Francisco, California.
Triple Jump Medical — Triple Jump Medical is a developer of an insulin pump intended to treat diabetic patients.
Sensible Medical Innovations — Sensible Medical Innovation Ltd. is introducing a breakthrough sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today’s biggest burden on US and worldwide healthcare budgets.

Michal Efrat Zarfati

Investment focus

Wearables, Medical Device, Rehabilitation
Seed, Pre-Seed
Israel

Portfolio highlights

6Degrees — 6Degrees has developed an adaptive hands free controller that gives people independence and choice by making devices accessible. Their patented wireless controller can be utilized to operate any smart device - including smart phones, tablets and PCs. Crescent has deep applicability in the fields of AR/VR, defense, and assistive technologies
Pink Of View —

Itsik Danziger - Chairman of the Board @ The Center for Educational Technology (CET)

Investment focus

Medical, Hospital, Health Care
Series A
Israel

Portfolio highlights

EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.

Daniel Koss is an individual investor.

Investment focus

Medical Device, Clinical Trials, Health Diagnostics
Seed
Israel

Portfolio highlights

MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable

Ole T. Jensen

Investment focus

Biotechnology, Medical Device
Funding Round
Israel

Portfolio highlights

Nobio — NobioTM developed game-changing technology with the goal to prevent medical device contamination indefinitely, as the first and only fully-integrated anti-biofilm solution. The technology core consists of extremely potent particles which are covered with a high concentration of highly-active anti-microbial structures that kill bacteria uponcontact. The NobioTM particles can be permanently embedded in many products and materials to inhibit formation of biofilm, indefinitely.

Avi Kornreich is a former CEO of Agentek.

Investment focus

Medical, Hospital, Health Care
Series A
Israel

Portfolio highlights

EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.

Tzachi Arabov is a owner of ACRO.

Investment focus

Medical Device, Clinical Trials, Health Diagnostics
Seed
Israel

Portfolio highlights

MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable

Jim Elkind is a private healthcare investor.

Investment focus

Medical, Hospital, Health Care
Series A
Israel

Portfolio highlights

EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.

Amir Gross is the CEO of Cardiovalve.

Investment focus

Medical, Health Care, Medical Device
Funding Round
Israel

Portfolio highlights

BrainQ — BrainQ is developing breakthrough precision neurology therapies using Brain Computer Interface technology....

Ran Tuttnauer

Investment focus

Health Care, Big Data, Medical Device
Seed, Series A
Israel, Canada, United States

Portfolio highlights

Innovopro — Bringing a unique chickpea protein platform to the global food & beverage market, for creating nutritious, tasty, and sustainable food products.
Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders.

Benny Levin is a founder and former CEO of NICE.

Investment focus

Medical, Hospital, Health Care
Series A
Israel

Portfolio highlights

EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.

Rafi Benary is the Co-founder at Innoventric and he holds a Masters’ degree from the New York University in Material Science and a Mechanical Engineering. He is an entrepreneur of 4 start-up companies, bringing them from inception to clinical stage through effective planning and execution.

Investment focus

Medical, Medical Device, Health Diagnostics
Pre-Seed
Israel

Portfolio highlights

Althea Medical — Althea Medical is a creator of catheter devices for the treatment of patients with sub- or major pulmonary emboli. The company is developing a catheter-based solution for treating patients suffering from massive and sub-massive Pulmonary Embolism (PE). Althea Medical was established in 2020 in Tel Aviv, Israel.

For the last 10 years, I have been active within the Israeli and US startup ecosystems where I completed 20+ seed investments in companies such as Geoforce (acquired by LLR), Bonobo (acquired by Salesforce), Optitex (acquired by Efi), Keeprz (acquired by Como), Drippler (acquired by Soluto), Snyk (Unicorn) and few others. I am passionate for seedinvestments, creative ideas, risk taking and supporting entrepreneurs.Prior to that, I founded 2 companies, Blue Sky (Energy) and Sinusafe (Medical) after working as a software engineer for 7 years.I grew up in Israel, and lived in the US for 5 years while completing my MBA from Duke. I love all kinds of extreme sports, and particularly kite surfing and snowboarding.

Investment focus

Software, Artificial Intelligence, Machine Learning
Seed, Funding Round, Series B
Israel, United States

Portfolio highlights

Laxis — Learn how UX designers, product managers, market research, consultants, and attorneys use conversation Intelligence to supercharge their business and increase revenue. Learn more.
Deci AI — Deci enables deep learning to live up to its true potential by using AI to build better AI. With the company’s end-to-end deep learning acceleration platform, AI developers can build, optimize, and deploy faster and more accurate models for any environment, including cloud, edge or mobile. With Deci’s platform, developers can increase deeplearning model inference performance by 3x-15x, on any hardware, while still preserving accuracy. This translates directly into new use cases on limited hardware, substantially shorter development cycles, and reduced compute costs by up to 80%. The platform is powered by Deci’s Automated Neural Architecture Construction (AutoNAC) technology, an algorithmic optimization engine that squeezes maximum utilization out of any hardware. The AutoNAC engine contains a Neural Architecture Search (NAS) component that redesigns a given trained model’s architecture to optimally improve its inference performance (throughput, latency, memory, etc.) for specific target hardware while preserving its baseline accuracy. Deci achieved a record-breaking 11.8x accelerated inference speedup on Intel CPUs at MLPerf Industry Benchmark and has been named to the CBInsights top 100 AI companies. Led by a team of world-class deep learning experts, Deci lets AI developers focus on what they do best - creating innovative AI-based solutions for our world’s most complex problems.
Velocity — Accelerate the way you build and deliver products. Spin up fully isolated, production-like environments in seconds. Work with your existing dev toolbox.

Investors by industry